Ayson, Arjhon D.
HRN: 22-71-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2023
08/12/2023
IV DRIP
240 Mg
Q8
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes